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Figure 1. Ultrasonography of 50-year-old male showed a large 
hepatic mass with internally heterogeneous echo.
INTRODUCTION
Hepatic hemangioma is the most common benign tumor of the 
liver. Recently its frequency of detection has increased with the 
introduction of nation-wide cancer screening programs and 
technical improvement of radiological modalities such as computed 
tomography (CT) and ultrasonography. Radiological findings of 
typical hemangioma are well-known. However, sometimes, 
there are some atypical findings of hemangioma due to com-
plications such as thrombosis, infarction, hemorrhage or 
sclerosis.
1,2 Therefore, they can be frequently misdiagnosed and 
confused with other malignant hepatic tumors. 
In this report, a case of sclerosing hepatic hemangioma is 
presented with radiological findings.
CASE
A 50-year-old male was admitted with the complaint of an 
incidentally detected liver mass. He has lost 6 kg weight during 
recent 2 months, so he took precise health examination, and he 
was diagnosed as diabetes mellitus. Also a large hepatic mass 
was detected on abdominal CT scan. He did not present specific 
symptoms such as abdominal pain or anorexia. Physical ex-
amination revealed no specific findings such as hepatomegaly, 
either. 
The laboratory findings showed red blood cell count of 
5.33×10
6/mm
3, hemoglobin level of 16.3 g/dL, and hematocrit of 
46.8%. White blood cell count was 6,800/mm
3 and platelet count 
was 282,000/mm
3. Biochemical tests showed that the serum 
level of alanine aminotransferase was 26 IU/L, aspartate 
aminotransferase was 23 IU/L, and alkaline phosphatase was 98 
IU/L. Serum protein was 7.6 g/dL and albumin was 4.2 g/dL. 
Total bilirubin was 0.8 mg/dL. Alpha-fetoprotein was 2 ng/mL, 
and carcinoembryonic antigen was 0.79 ng/mL. The results for 
hepatitis B surface (HBs) antigen and anti-HBs were negative. 
Ultrasonography showed large liver mass in right lobe (Fig. 1). 
It showed well marginated mass with internally heterogeneous 
mixed echo containing echogenic area and hypoechoic area. CT 
showed 10 cm sized and irregular homogenously low attenuated 
round masses in the liver on precontrast scan (Fig. 2A). It showed 
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Figure 2. Dynamic contrast enhanced CT scans. (A) Precontrast CT scan revealed large irregular homogenously 
low attenuated mass in liver right lobe. There was no calcification or hypoattenuated area in the mass. (B) Arterial 
phase of dynamic contrast enhanced CT scan showed large irregular, patch enhancement in peripheral area of 
mass. (C and D) Portal phase and delayed phase of CT scan showed gradual progressive centripetal enhancement 
from periphery to central area, except for central areas of low attenuation probably representing sclerosis.244  The Korean Journal of Hepatology Vol. 17. No. 3, September 2011
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Figure 3. Dynamic contrast enhanced MRI 
scans. (A) T1 weighted image showed large 
low signal intensity mass in liver. (B, C, and D)
After contrast enhancement, the mass showed 
similar enhancement pattern with those of 
dynamic CT scans. (E) T2 weighted image 
showed high signal intensity mass including 
central area which was not enhanced on 
contrast-enhanced scans and was suspected as 
sclerotic area.Yong Moon Shin. Sclerosing hemangioma in the liver  245
Figure 4. FDG-PET scan showed iso to slightly decreased metabolic activity in the right lobe of liver.
area, and enhancement advanced into the central area gradually 
on portal phase and delayed phase (Fig. 2B-D). There was partial 
central unenhanced low attenuation area on delayed phase.
Magnetic resonance imaging (MRI) showed similar enhancement 
pattern with dynamic CT scan (Fig. 3A-D). Contrast enhancement 
was done with gadolinium-BOPTA (Multihance
®, TaeJoon, 
Seoul, Korea), and images were taken at 10, 50 and 300 seconds 
after contrast injection. On T2-weighted image, the mass showed 
diffuse homogenous high signal intensity including the central 
area which was not enhanced on delayed phase contrast- 
enhanced scan (Fig. 3E). The Central unenhanced area was 
suggested as sclerotic mesenchyma, not necrosis. 
Fluorodexoyglucose positron emission tomography (FDG- 
PET) scan showed iso- to hypometabolic mass in right lobe of the 
liver (Fig. 4). 
The mass was radiologically diagnosed as sclerosing hemangioma. 
Percutaneous fine-needle-aspiration biopsy was performed in 
right lobe mass under ultrasound guidance for differential 
diagnosis with cholangiocellular carcinoma. Histological examination 
of the biopsy specimen showed cavernous hemangioma with 
sclerosis. The final diagnosis was sclerosing hemangioma. 
DISCUSSION
Cavernous hemangiomas of the liver can be found incidentally 
and may be readily diagnosed due to their characteristic 
radiological findings. Hemangiomas consist of endothelium-lined 
blood-filled spaces separated by fibrous septa. Cavernous 
hemangiomas in the liver usually present as solitary well- 
delineated, subcapsular, discolored nodules that are smaller than 
5 cm.
3 They can exhibit various forms of pathology, such as 
necrosis, scarring, and calcification, some of which mimic the 
primary or metastatic malignancy.
The characteristic radiological findings of hepatic hemangiomas 
are: 1) homogenous hyperechogenic mass on ultrasonography, 2) 
low attenuation mass on precontrast scan, 3) early peripheral 
contrast enhancement with nodular pattern, 4) progressive 
opacification from periphery to the center, 5) eventual isodense 
fill-in on delayed contrast scan of CT or MRI, 6) “light-bulb” like 
very high signal intensity on heavily T2-weighted image on 
MRI. With the typical hemangiomas, imaging modalities are 
highly reliable for diagnosis, especially MRI, which has a 
sensitivity and specificity of  >90%. However, only about 50% of 
all hemangiomas show these typical radiological findings.
4 The 
diagnosis of some atypical hemangiomas remains uncertain with 
an MRI study owing to the presence of intralesional thrombosis 
or calcified, hyalinized, or cystic components that result in the 
loss of its characteristic appearance of markedly high signal 
intensity on heavy T2-weighted imaging and present with atypical 
enhancement patterns on postenhanced study.
5 In these cases, it 
can lead to misdiagnosis and confusion with other hepatic tumors 
including malignant tumor. So, these cases require biopsy and 
histopathological examination. 
Some pathological changes are responsible for the variations 
of the radiological findings of hemangioma. Of these complications, 
sclerosing hemangiomas can have a variable amount of stroma, 
varying from scanty (fibrillar or hyaline) to abundant (hyaline or 
sclerotic), and sclerosed hemangiomas are characterized by 
extensive fibrosis with subsequent hyalinization and marked 
narrowing or obliteration of the vascular spaces.
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and Ishak have reported that there are distinct clinical and 
histopathological differences between sclerosing and sclerosed 
hemangiomas; they suggested that recent hemorrhages and 
hemosiderin deposits, rich with mast cells are present in the 
sclerosing hemangioma.
6 Moreover, fibrosis, increased elastic 
fibers, and dystrophic or psammomatous calcifications with a 
decreased number of mast cells can be observed in the sclerosed 
hemangioma.
6
The radiological findings of sclerosing and sclerosed heman-
giomas have rarely been reported. Sclerosing hemangiomas may 
show mild to moderate hyperintensity on T2 weighted MRI 
images, patchy central enhancement during the arterial phase, 
and gradual progressive enhancement during the portal venous 
and the delayed phases, except in the central area, mimicking 
hepatocellular carcinoma.
7 Another report showed only marginal 
enhancement on CT hepatic arteriography, whereas most parts 
remain a perfusion defect; they may also show marginal pooling 
on CT and MRI during the delayed phase, mimicking metastatic 
tumors.
8 Many other reports showed that delayed enhancement 
on dynamic CT and the hypointensity relative to fluid on 
T2-weighted MRI may correspond to sclerosis.
2,5 Unlike typical 
hemangiomas, peripheral globular enhancement was not seen 
and, instead, multifocal patchy enhancement was seen during the 
arterial phase, but this was less intense than that of the hepatic 
artery. Also, patchy progressive tumoral enhancement seen 
during the portal venous and the delayed phases was less intense 
than that of the hepatic parenchyma in most of the mass. Most 
parts of the mass showed intermediate signal intensity on T2 
weighted images. Pathologically, these atypical radiological 
features were attributed to prominent sclerosis and marked 
narrowing of vascular spaces. The lower globular enhancement 
compared with that of the hepatic vessels, together with the 
intermediate signal intensity on T2 weighted images may 
correspond with compression of vascular spaces owing to 
pericapillary smooth muscle proliferation.
5 According to above 
findings, differential diagnosis with hepatocelluar carcinoma, 
cholangiocellular carcinoma, metastasis or organized abscess is 
sometimes difficult. So, pathological confirmation might be 
needed. 
It has been postulated that central non-opaicified areas might 
be related to slow blood flow in the central sinusoids, necrosis, 
fibrosis, central thrombosis, or hemorrhage.
4 In another report, 
consistent low attenuation on unenhanced and dynamic CT scans 
and bright high signal intensity on T2 weighted MR images, was 
pathologically composed of a hyalinized portion.
5 It is particularly 
important that CT appearances of sclerotic nodule in hepatic 
hemangioma might be confused with other malignant tumors 
with necrosis.
4 However, in our case, there was unenhanced area 
on delayed phase scan, but it did not present more hypoattenuated 
area on unenhanced scan nor higher signal intensity areas on T2 
weighted MR images, so it was postulated as sclerosing mesenchyma 
with very slow contrast enhancement, not hyalinized area. 
In conclusion, although sclerosis and other pathological 
complications are rare in hepatic hemangiomas, an awareness of 
this complication and an understanding of the pathological 
background of its atypical radiological appearances are important. 
Percutaneous biopsy may make unnecessary surgery avoidable.
SUMMARY
In the present case above, the mass showed high signal intensity 
on T-2 weighted images as like typical hemangioma. However, 
typical peripheral nodular enhancement was not seen and there 
was central unenhanced low attenuated area until delayed phase 
on CT and MRI, so sclerosing hemangioma was suspected. To 
differentiate from other hepatic tumors, biopsy was done, and 
pathologically sclerosing hemangioma was confirmed.
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